Skip to main content

Month: March 2023

Adfenix to rise again as Realforce

Following two key acquisitions, property marketing platform, Adfenix, adopts a new name as a first-of-its-kind Marketing Operations platform for the property industry. GOTHENBURG, Sweden, March 20, 2023 (GLOBE NEWSWIRE) — Used by thousands of estate agencies around the world, Adfenix has long been known for its high-performing social media advertising campaigns and lead-generation capabilities. In acquiring customer data company Quedro and media management company Brandkeeper over the last 18 months, Adfenix made it clear that it had ambitions beyond social media advertising. The new Realforce product universe is engineered to provide support to the underappreciated marketing team, tasked with supporting estate agents with their marketing needs. Organised, automated, AI-powered and data-backed, Realforce puts the power in the hands...

Continue reading

Vaxxinity Announces First Subjects Dosed in Phase 1 Clinical Trial of VXX-401, Investigational Anti-PCSK9 Vaccine to Treat Hypercholesterolemia

CAPE CANAVERAL, Fla., March 20, 2023 (GLOBE NEWSWIRE) — Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of immunotherapeutic vaccines, today announced that the first subjects have been dosed in a randomized, double-blind, placebo-controlled Phase 1 clinical trial of VXX-401, an investigational vaccine designed to lower low-density lipoprotein (LDL) cholesterol, a known factor contributing to heart disease, by targeting proprotein convertase subtilisin/kexin type 9 serine protease (PCSK9). Heart disease remains the leading cause of death globally, claiming over 18 million lives per year, despite the existence of approved treatments that lower LDL. “This is an exciting milestone for VXX-401 and Vaxxinity in our pursuit to vaccinate the world against heart disease with a preventative option...

Continue reading

Freehold Royalties Announces Executive Team Update

CALGARY, Alberta, March 20, 2023 (GLOBE NEWSWIRE) — Freehold Royalties Ltd. (Freehold or the Company) (TSX:FRU) is pleased to announce two internal promotions within the Company’s executive team. Effective April 1, 2023, Rob King will be appointed as Chief Operating Officer and Susan Nagy will be appointed as Vice President, Business Development. Mr. King joined Freehold in 2020 as Vice President, Business Development where he was instrumental in the Company’s expansion into the U.S. Mr. King oversaw the execution of over $550 million in value-enhancing transactions over the last two years, as Freehold expanded its North American footprint, as well as oversaw various optimization initiatives on Freehold’s Canadian legacy acreage. As Chief Operating Officer, Mr. King will provide enhanced senior level leadership in respect of the...

Continue reading

Norwegian Cruise Line Holdings Ltd. Announces CEO Retirement and Succession Plan

Frank Del Rio Frank J. Del Rio, current President and CEO of NCLHHarry Sommer Harry Sommer, Incoming President and CEO of Norwegian Cruise Line HoldingsFrank J. Del Rio to Retire After Illustrious 30-Year Career in the Cruise Industry, Effective June 30, 2023 Harry J. Sommer, President and Chief Executive Officer of Norwegian Cruise Line, Appointed Company’s Next President and Chief Executive Officer David J. Herrera Appointed President of Norwegian Cruise Line MIAMI, March 20, 2023 (GLOBE NEWSWIRE) — Norwegian Cruise Line Holdings Ltd. (the “Company” or “NCLH”) (NYSE: NCLH), a leading global cruise company which operates the Norwegian Cruise Line (“NCL”), Oceania Cruises and Regent Seven Seas Cruises brands, today announced that Frank J. Del Rio has decided to retire and step down from his position as the Company’s...

Continue reading

Snakes & Lattes Inc. Acquires a New Brick & Mortar Location in Virginia Beach, Virginia

TORONTO, ON, March 20, 2023 (GLOBE NEWSWIRE) — via NewMediaWire — Snakes & Lattes Inc. (OTC: FUNN) is pleased to announce the acquisition of ‘Roll With It’ Board Game Cafe & Bar (Roll With It) in Virginia Beach, Virginia via an all cash transaction. Acquisition Highlights:Completed acquisition of ‘Roll With It’ Board Game Café & Bar in Virginia Beach All cash deal  Very popular, Operating Café & Bar with little competition in the area Strong revenue, well managed, with a similar company culture Over 4700 sq. ft. in a high-traffic area with lots of visibility and parking. Marks the first location on the East Coast of the USA (5th USA location To Date)Established in August 2021 by Quan Truong, ‘Roll With It’ is extremely well managed, has a great company culture, strong revenue and little to no competition...

Continue reading

Heidmar Inc. Announces Business Combination Agreement with Home Plate Acquisition Corporation

Heidmar Inc., a first-class commercial and pool management business servicing the crude oil and refined petroleum product tanker market announces plan to list on Nasdaq through merger with Home Plate Acquisition Corporation (NASDAQ GM: HPLT) HighlightsSingle platform aggregator of maritime services for tanker industry with unique asset light business model Strong cash position and no debt provides high flexibility for future growth Targeting minimum cash raise of $55 million, in a combination of expected PIPE raise and Trust cash Predictable fee-based earnings to further isolate Heidmar from freight rate exposure Targeted $0.30 per share dividend post-combination implies a sustainable yield of ~3% at a $10.00 per share price Pro forma equity value of the combined company would be approximately $261.4 million1ATHENS, Greece, March...

Continue reading

Athenex Provides Fourth Quarter and Full Year 2022 Financial Results and Business Update

Exploring a range of strategic alternatives Revenues from product sales from continued operations increased +27% Y/Y in 4Q 2022 and +33% for full year 2022 Net Loss attributable to Athenex was $34.2 million, or $4.28 per diluted share in 4Q2022, compared to $104.4 million, or $19.08 per diluted share, in the prior year quarter Cash, cash equivalents, and restricted cash balance of $35.6 million at year end Additional Phase 1 dose escalation study safety and preliminary efficacy data for KUR-502 CAR-NKT cell therapy product anticipated in 2H 2023 Phase 1 GINAKIT2 study of KUR-501 on clinical hold; pending serious adverse event investigation and safety risk mitigation planning to reopen clinical trial Graduation of Oral Paclitaxel combination regimen in the neoadjuvant triple-negative breast cancer treatment subgroup of I-SPY 2 trial BUFFALO,...

Continue reading

3D Systems Collaborates with TE Connectivity on Innovative Solution to Additively Manufacture Electrical Connectors

Novel workflow enables production of end-use parts in weeks versus months without tooling investment Unique photopolymer introduced with full UL recognition capable of meeting stringent connector application needs First known 3D photopolymer to complete long-term thermal aging for electrical and mechanical relative thermal index (RTI) certification.ROCK HILL, S.C., March 20, 2023 (GLOBE NEWSWIRE) — 3D Systems (NYSE:DDD) today announced its collaboration with TE Connectivity, a world leader in connectors and sensors, to jointly develop an additive manufacturing solution to produce electrical connectors meeting stringent UL regulatory requirements. The solution comprising 3D Systems’ Figure 4® Modular, Figure 4 material, 3D Sprint® software, and services was designed to meet TE Connectivity’s unique requirements for material performance...

Continue reading

PFSweb Announces Authorization of Share Repurchase Program

IRVING, Texas, March 20, 2023 (GLOBE NEWSWIRE) — PFSweb, Inc. (NASDAQ: PFSW) (the “Company”), a premier eCommerce order fulfillment provider, announced that its board of directors has authorized a share repurchase program, under which the Company may purchase up to an aggregate of 1,000,000 shares of its common stock. The program will be in place for up to two years. Subject to applicable rules and regulations, the shares may be purchased from time to time in the open market or in privately negotiated transactions. The share repurchase program will be conducted in accordance with Rule 10b-18 under the Securities Exchange Act of 1934, as amended. Such purchases will be at times and in amounts as PFSweb deems appropriate, based on factors such as market conditions, legal requirements, and business considerations. The share repurchase...

Continue reading

QSAM Biosciences to Provide Updates on its Clinical Trial at the Emerging Growth Conference on Wednesday, March 22, 2023

QSAM invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference. Austin, TX, March 20, 2023 (GLOBE NEWSWIRE) — QSAM Biosciences, Inc. (OTCQB: QSAM), a company developing next generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP (CycloSam®), for the treatment of bone cancer and related diseases and conditions, is pleased to announce that it has been invited to provide updates on its clinical trial evaluating CycloSam® for the treatment of metastatic bone cancer at the Emerging Growth Conference on Wednesday, March 22, 2023, at 2:50 PM EST. The Emerging Growth Conference is a live, interactive online event that will give existing shareholders and the investment community the opportunity to interact with the...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.